TOC
Home > People at the DRFZ > Dr. Andrey Kruglov

Dr. Andrey Kruglov

Programme Area 3, PA 3 – Systems Rheumatology

Group leader: Chronic Inflammation

Scientific Background

Since 2016rnGroup Leader at DRFZ, Berlin, Germanyrnrn2013-2022rnLeading Staff Scientist at A.N. Belozersky Institute of Physico-chemical Biology, M.V. Lomonosov Moscow State University, Moscow, Russiarnrn2015-2016rnGuest Scientist at DRFZ, Berlin, Germanyrnrn2009-2015rnPostdoctoral Scientist at DRFZ, Berlin, Germany

2004-2009rnPhD in Biology, Engelhardt Insitute of Molecular Biology, Moscow, Russiarnrn1999-2004rnMaster of Science in Chemistry, Chemistry Department, M.V. Lomonosov Moscow State University, Msocow, Russia

Since 2022rnOrganisation of B cell seminar at DRFZrnrn2022-2024rnAd-hoc reviewer for Gut Microbes, Gastroenterology, cellular immunology and etc.rnrn2022-2024rnReviewer of grant proposal for CNRS and SNSF

Since 2012rnMember of German Society of Immunology (DGFI)

2021rnLeibniz Research Alliance Bioactive Compounds and Biotechnology: “Identification of protein structures resembling RBD of SARS-CoV-2 by human commensal microrganisms” PI: Andrey Kruglov and Co-PI: Jorg Overmann.

Kruglov lab

Significance of immune system, cytokines and microbiota interplay for the development of chronic inflammation